Stephen Hill has served as our Chief Technical Operations Officer since June 2019. From June 2018 to June 2019, he was Senior Vice-President, Head of Global Biologics Operations and from March 2016 to June 2018 as Vice-President, Site Head at AstraZeneca, a publicly-traded company. From December 2012 through February 2016, Mr. Hill served in multiple positions at Amgen, including as Vice President, Bulk Manufacturing , Executive Director, Plant Manager and Executive Director, Manufacturing Technologies. Mr. Hill received an MBA and a B.S. in Microbiology and B.A. in Political Science from the University of Washington.